The protective effect of alpha-lipoic acid on cardiovascular diseases caused by oxidative stress
Journal Title: Серце і судини - Year 2018, Vol 0, Issue 1
Abstract
The article is devoted to the consideration of protective properties of alpha-lipoic acid using in cardiac patients, including those with concomitant type 2 diabetes mellitus, which constitute a group of high and very high cardiovascular risk. The modern pathogenetic mechanisms of vascular wall damage in endothelial dysfunction, oxidative stress in cardiac patients, including those with concomitant type 2 diabetes mellitus, are considered in details. Particular attention in the article was paid to the role of pathogenetic based therapy using alpha-lipoic acid, which has a wide spectrum of pleiotropic effects, which affects oxidative stress indicators, atherogenic dyslipidemia and endothelial dysfunction, inflammation, atherosclerosis. Systematically, based on data from evidence-based medicine, features of the effects of alpha-lipoic acid on metabolic processes in the body are highlighted, it’s role in the antioxidant defense system, as well as it’s cytoprotective properties described, which justifies the rationality of the use of alpha-lipoic acid in cardiac patients.
Authors and Affiliations
L. V. Zhuravlyova, N. A. Lopina
Keywords
Related Articles
- EP ID EP279550
- DOI -
- Views 141
- Downloads 0
Determination of indications for and long-term results of femoral-popliteal (distal) alloshunting using polytetrafluoroethylene implants in patients with obliterating atherosclerosis on the background of critical ischemia
The aim — improvement of the results of reconstructive operations in patients with obliterating atherosclerosis of the vessels of lower extremities with multiple occlusal‑stenotic lesions on the background of critical i...
Risk factors for death at long-term follow-up after acute coronary syndrome in patients with atrial fibrillation
The aim — to evaluate the predictive significance of clinical, instrumental and laboratory parameters regarding the mortality of patients with acute coronary syndrome (ACS) and atrial fibrillation (AF) at long‑term foll...
Growth differentiation factor 15 — biomarker of poor prognosis in heart failure
Heart failure (HF) is a major factor contributing to premature death in patients with established cardiovascular (CV) disease. There is a large body of evidence that biological markers, primarily natriuretic peptides, ga...
Changes in the quality of life of patients with stable ischemic heart disease and preserved left ventricular ejection fraction after coronary artery bypass grafting or stenting at 6-month follow-up
The aim — to compare the changes of the values of quality of life (QoL) in patients with stable coronary artery disease and preserved left ventricular (LV) ejection fraction (EF) within 6 months after revascularization i...
Vertebrobasilar infarctions: principles of classification, clinical and neuroimaging analysis and terminological definitions of the diagnosis
The aim — to describe the neurological clinic, specific symptoms and syndromes in patients with acute infarction of various anatomical and vascular territories of the posterior circular pool, to justify the use in clinic...